News
Subscribe to our news & insights
Insights
21 April 2025
Women’s health matters: Unlocking investment opportunities beyond…
In 2023, the global women’s health market was valued at US$250-300…
17 April 2025
Southeast Asia Healthcare Distribution: Delivering value
We assessed both the medical devices (Medtech) and pharmaceutical…
9 April 2025
Wind thought piece – Onshore tailwinds
The global wind industry is entering a new era of growth. The need to triple…
About us
We are a premium provider of Asia-related advice to sophisticated clients globally, with over 25 years’ experience and a strong track record for advising corporates and financial sponsors on cross-border M&A, capital raising, and financial restructuring.
As the leading sellside investment banking advisor for Asia, we specialize in cross-border transactions and have over 120 bankers throughout our nine offices located across North America, Europe and Asia.
At a glance
#1
Cross-border Asian sellside M&A advisor†
1996
Founded and led since then by the same senior team
80%
Of transactions are cross-border
120+
Bankers collaborating seamlessly across three continents
Recent transactions
received investment from PATRIZIA and Mitsui (APAC Sustainable Infrastructure Fund)
2025
Services
has divested strategic stake to
2025
Health
sold controlling stake to
2025
Technology
divested
to
2025
Industrials
divested automotive audio manufacturing operations to
2025
Consumer
and other shareholders divested a controlling stake in
to
2025
Technology
acquired 100% stake in
from
2024
Services
sold
to
2024
Industrials
divested stake in
to
2024
Industrials
†Private companies headquartered in China, India, Japan, Korea or Southeast Asia; Control transactions up to US$1bn enterprise value, 2016-2022 Source: Dealogic